MEDICAL PROPERTIES TRUST INC Financial Ratios
MPT|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-12.1%
Profit Margin
-63.8%
Net Income / Revenue
Asset Turnover
0.06
Revenue / Total Assets
Equity Multiplier
3.26
Total Assets / Equity
Composite: -12.1% (reported: -12.1%)
Profitability
Gross Margin
-
Operating Margin
-
EBITDA
$340.1M
EBITDA Margin
39.0%
Liquidity
Current Ratio
-
Quick Ratio
-
Solvency
Interest Coverage
1.23
Efficiency
Asset Turnover
0.06
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-7.2%
-8.4pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.